Effect of Intravenous Iron Isomaltoside on Postoperative Anemia in Patients Underwent Total Knee Arthroplasty: A Single-blind Randomized Controlled Trial
Phase of Trial: Phase IV
Latest Information Update: 22 Apr 2019
Price : $35 *
At a glance
- Drugs Ferric derisomaltose (Primary)
- Indications Iron deficiency anaemia
- Focus Therapeutic Use
- 16 Apr 2019 Status changed from recruiting to completed.
- 25 Feb 2019 Planned number of patients changed from 94 to 100.
- 25 Feb 2019 Planned End Date changed from 31 Mar 2019 to 30 Jun 2019.